How can we optimise learning from trials in child and adolescent mental health?
Child & adolescent psychiatry
Journal
Evidence-based mental health
ISSN: 1468-960X
Titre abrégé: Evid Based Ment Health
Pays: England
ID NLM: 100883413
Informations de publication
Date de publication:
12 Jul 2022
12 Jul 2022
Historique:
received:
21
04
2022
accepted:
15
06
2022
entrez:
12
7
2022
pubmed:
13
7
2022
medline:
13
7
2022
Statut:
aheadofprint
Résumé
Improving child and adolescent mental health requires the careful development and rigorous testing of interventions and delivery methods. This includes universal school-based mindfulness training, evaluated in the My Resilience in Adolescence (MYRIAD) trial reported in this special edition. While discovering effective interventions through randomised controlled trials is our ultimate aim, null or negative results can and should play an important role in progressing our understanding of what works. Unfortunately, alongside publication bias there can be a tendency to ignore, spin or unfairly undermine disappointing findings. This creates research waste that can increase risk and reduce benefits for future service users. We advocate several practices to help optimise learning from all trials, whatever the results: stronger intervention design reduces the likelihood of foreseeable null or negative results; an evidence-informed conceptual map of the subject area assists with understanding how results contribute to the knowledge base; mixed methods trial designs aid explanation of outcome results; various open science practices support the dispassionate analysis of data and transparent reporting of trial findings; and preparation for null or negative results helps to temper stakeholder expectations and increase understanding of why we conduct trials in the first place. To embed these practices, research funders must be willing to pay for pilot studies and 'thicker' trials, and publishers should judge trials according to their conduct and not their outcome. MYRIAD is an exemplar of how to design, conduct and report a trial to optimise learning, with important implications for practice.
Identifiants
pubmed: 35820994
pii: ebmental-2022-300500
doi: 10.1136/ebmental-2022-300500
pmc: PMC10231499
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
JAMA Pediatr. 2018 Sep 1;172(9):807-809
pubmed: 30039164
J Stud Alcohol Drugs. 2018 Mar;79(2):171-181
pubmed: 29553343
J Epidemiol Community Health. 2015 Jan;69(1):95-8
pubmed: 25403381
PLoS Biol. 2016 May 12;14(5):e1002456
pubmed: 27171007
Prev Sci. 2022 Jul;23(5):751-763
pubmed: 32748164
BMJ Qual Saf. 2016 May;25(5):303-10
pubmed: 26442789
Trials. 2014 Jun 09;15:215
pubmed: 24913438
Lancet. 2014 Jan 11;383(9912):166-75
pubmed: 24411645
Psychol Med. 2018 Nov;48(15):2453-2455
pubmed: 30070192
Child Dev Perspect. 2020 Mar;14(1):3-8
pubmed: 33981356
BMJ. 2021 Sep 30;374:n2061
pubmed: 34593508
Lancet Psychiatry. 2022 Jul;9(7):584-594
pubmed: 35525252
J Child Psychol Psychiatry. 2018 Aug;59(8):829-830
pubmed: 29992597
N Engl J Med. 2008 Jan 17;358(3):252-60
pubmed: 18199864
CMAJ. 2006 Aug 15;175(4):347
pubmed: 16908892
Lancet Psychiatry. 2019 Dec;6(12):1011-1020
pubmed: 31734106
BMJ Open. 2019 Nov 26;9(11):e032081
pubmed: 31772096
PLoS One. 2015 Aug 05;10(8):e0132382
pubmed: 26244868
Lancet Psychiatry. 2021 May;8(5):353-354
pubmed: 33444548